XML 19 R9.htm IDEA: XBRL DOCUMENT v3.22.1
Equity-Based Compensation
3 Months Ended
Mar. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Equity-Based Compensation

Note 3: Equity-Based Compensation

 

The fair value of each option and equity warrant award is estimated on the date of grant using a Black-Scholes-Merton option pricing valuation model. Expected volatility is based on the historical volatility of the price of the Company’s stock. The risk-free interest rate is based on U.S. Treasury issues with a term equal to the expected life of the option and equity warrant. The Company uses historical data to estimate expected dividend yield, expected life and forfeiture rates. During the three months ended March 31, 2022 there were 300,000 options granted and no options granted in the three months ended March 31, 2021.

 

Stock option for employees’ activity during the three months ended March 31, 2022, is as follows:

 

Stock option activity for employees:

 

   Number of
Options
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Term
(Years)
   Aggregate
Intrinsic
Value
 
Outstanding January 1, 2022   1,498,798   $4.22    9.11   $ 
Granted   150,000    0.70    9.75     
Forfeited       233.54         
Expired   (739)            
Outstanding March 31, 2022   1,648,059   $3.80    8.94   $ 
Vested and expected to vest March 31, 2022   1,648,059   $3.80    8.94   $ 
Exercisable March 31, 2022   1,216,894   $3.15    6.08   $ 

 

Unvested stock option activity for employees:

 

   Number of
Options
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Term
(Years)
   Aggregate
Intrinsic
Value
 
Unvested January 1, 2022   412,500   $4.15    5.85   $ 
Granted   150,000    0.70    9.75     
Expired   (739)   233.54         
Vested   (130,596)   1.52    9.88     
Unvested March 31, 2022   431,165   $2.69    7.32   $ 

 

 

Stock option activity for non-employees:

   Number of
Options
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Term (Years)
   Aggregate
Intrinsic
Value
 
Outstanding January 1, 2022   279,723   $6.12    7.93   $ 
Granted   150,000    0.70    9.75     
Forfeited                
Expired                
Outstanding March 31, 2022   429,723   $4.23    8.40   $ 
Vested and expected to vest March 31, 2022   429,723   $4.23    8.40   $ 
Exercisable March 31, 2022   222,770   $6.05    7.96   $ 

 

Unvested stock option activity for non-employees:

   Number of
Options
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Term
(Years)
   Aggregate
Intrinsic
Value
 
Unvested January 1, 2022   97,831   $3.89    7.82   $ 
Granted   150,000    0.70    9.75     
Expired                
Vested   (40,878)   1.35         
Unvested March 31, 2022   206,953   $3.66    7.60   $ 

 

Stock-based compensation expense was approximately $242,000 and $526,000 for the three months ended March 31, 2022 and 2021, resulting in an increase in general and administrative expenses, respectively.

 

As March 31, 2022, and 2021, respectively, there was approximately $729,000 and $914,000 of unrecognized equity-based compensation cost related to options granted under the Equity Incentive Plan.